138 related articles for article (PubMed ID: 20430663)
41. Lateral high abdominal ovariopexy: an original surgical technique for protection of the ovaries during curative radiotherapy for Hodgkin's disease.
Gaetini A; De Simone M; Urgesi A; Levis A; Resegotti A; Ragona R; Anglesio S
J Surg Oncol; 1988 Sep; 39(1):22-8. PubMed ID: 3419167
[TBL] [Abstract][Full Text] [Related]
42. Laparoscopic lateral ovarian transposition before radiation treatment of Hodgkin disease.
Howard FM
J Am Assoc Gynecol Laparosc; 1997 Nov; 4(5):601-4. PubMed ID: 9348369
[TBL] [Abstract][Full Text] [Related]
43. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease.
Le Floch O; Donaldson SS; Kaplan HS
Cancer; 1976 Dec; 38(6):2263-8. PubMed ID: 826312
[TBL] [Abstract][Full Text] [Related]
44. Effect of radiation on age at menopause among atomic bomb survivors.
Sakata R; Shimizu Y; Soda M; Yamada M; Hsu WL; Hayashi M; Ozasa K
Radiat Res; 2011 Dec; 176(6):787-95. PubMed ID: 21988524
[TBL] [Abstract][Full Text] [Related]
45. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy.
Hwang JH; Yoo HJ; Park SH; Lim MC; Seo SS; Kang S; Kim JY; Park SY
Fertil Steril; 2012 Jun; 97(6):1387-93.e1-2. PubMed ID: 22464082
[TBL] [Abstract][Full Text] [Related]
46. Ovarian function following radiation and chemotherapy for cancer.
Lo Presti A; Ruvolo G; Gancitano RA; Cittadini E
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113 Suppl 1():S33-40. PubMed ID: 15041128
[TBL] [Abstract][Full Text] [Related]
47. [Normal tissue tolerance to external beam radiation therapy: bone marrow].
Drouet F; Lagrange JL
Cancer Radiother; 2010 Jul; 14(4-5):392-404. PubMed ID: 20598617
[TBL] [Abstract][Full Text] [Related]
48. [Radiation dose in critical organs due to non-coplanar irradiation of the hypophysis].
Schulte RW; Rittmann KL; Meinass HJ; Rennicke P
Strahlenther Onkol; 1996 Sep; 172(9):501-6. PubMed ID: 8928057
[TBL] [Abstract][Full Text] [Related]
49. [Normal tissue tolerance to external beam radiation therapy: larynx and pharynx].
Debelleix C; Pointreau Y; Lafond C; Denis F; Calais G; Bourhis JH
Cancer Radiother; 2010 Jul; 14(4-5):301-6. PubMed ID: 20598610
[TBL] [Abstract][Full Text] [Related]
50. Do cancer therapies damage the uterus and compromise fertility?
Griffiths MJ; Winship AL; Hutt KJ
Hum Reprod Update; 2020 Feb; 26(2):161-173. PubMed ID: 31863097
[TBL] [Abstract][Full Text] [Related]
51. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
52. [Normal tissue tolerance to external beam radiation therapy: cardiac structures].
Doyen J; Giraud P; Belkacemi Y
Cancer Radiother; 2010 Jul; 14(4-5):319-26. PubMed ID: 20547085
[TBL] [Abstract][Full Text] [Related]
53. [Normal tissue tolerance to external beam radiation therapy: testicles].
Champetier C; Gross E; Pointreau Y; Zaccariotto A; Dubergé T; Guerder C; Ortholan C; Chauvet B
Cancer Radiother; 2010 Jul; 14(4-5):376-8. PubMed ID: 20418148
[TBL] [Abstract][Full Text] [Related]
54. Radiation dose and breast cancer risk in patients treated for cancer of the cervix.
Boice JD; Blettner M; Kleinerman RA; Engholm G; Stovall M; Lisco H; Austin DF; Bosch A; Harlan L; Krementz ET; Latouret HB; Merril JA; Petters LJ; Schulz MD; Wactawski J; Storm HH; Björkholm E; Pettersson F; Bell CM; Coleman MP; Fraser P; Neal FE; Prior P; Choi NW; Hislop TG; Koch M; Kreiger N; Robb D; Robson D; Thomson DH; Lochmüller H; von Fournier D; Frischkorn R; Kjørstad KE; Rimpela A; Pejovic MH; Kirn VP; Stankusova H; Pisani P; Sigurdsson K; Hutchison GB; MacMahon B
Int J Cancer; 1989 Jul; 44(1):7-16. PubMed ID: 2744900
[TBL] [Abstract][Full Text] [Related]
55. Measured dose to ovaries and testes from Hodgkin's fields and determination of genetically significant dose.
Niroomand-Rad A; Cumberlin R
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):745-51. PubMed ID: 8454491
[TBL] [Abstract][Full Text] [Related]
56. Use of a Small Animal Radiation Research Platform (SARRP) facilitates analysis of systemic versus targeted radiation effects in the mouse ovary.
Grover AR; Kimler BF; Duncan FE
J Ovarian Res; 2018 Aug; 11(1):72. PubMed ID: 30165884
[TBL] [Abstract][Full Text] [Related]
57. Role of ovarian transposition based on the dosimetric effects of craniospinal irradiation on the ovaries: a case report.
Mitchell JD; Hitchen C; Vlachaki MT
Med Dosim; 2007; 32(3):204-10. PubMed ID: 17707201
[TBL] [Abstract][Full Text] [Related]
58. Assessment of ovarian movement on consecutive pelvic MRI examinations in patients with gynaecological malignancies: what is the planning organ-at-risk volume for radiotherapy?
Peters NH; Patterson AJ; Horan G; Gregory D; Sala E
Br J Radiol; 2012 Oct; 85(1018):1407-14. PubMed ID: 22553297
[TBL] [Abstract][Full Text] [Related]
59. The effects of chemotherapy and radiotherapy on fertility in premenopausal women.
Fleischer RT; Vollenhoven BJ; Weston GC
Obstet Gynecol Surv; 2011 Apr; 66(4):248-54. PubMed ID: 21756407
[TBL] [Abstract][Full Text] [Related]
60. [Normal tissue tolerance to external beam radiation therapy: small bowel].
Martin E; Pointreau Y; Roche-Forestier S; Barillot I
Cancer Radiother; 2010 Jul; 14(4-5):350-3. PubMed ID: 20598616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
